News
The first ever treatment for Australians with a rare neurodegenerative disease could help slow the progression of its damage ...
The funds will be used to increase the development of GAIA-based Alzheimer's disease drugs and widen the pipeline of blockbuster drug candidates.
Biohaven Ltd. (NYSE:BHVN) is one of the Best 52-Week Low Stocks to Buy According to Analysts.. On June 10, Biohaven Ltd.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results